A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects.

NCT06481098 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: HM15275
DRUG: Placebo of HM15275

Sponsor

Hanmi Pharmaceutical Company Limited